Clinical Trial
Benefits and adverse drug experiences during long-term methotrexate treatment of 248 psoriatics
- PMID: 359259
Item in Clipboard
Clinical Trial
Benefits and adverse drug experiences during long-term methotrexate treatment of 248 psoriatics
Dan Med Bull.
1978 Oct.
No abstract available
Similar articles
-
[Clinico-biochemical parallels in the treatment of psoriasis with small doses of methotrexate].Vestn Dermatol Venerol. 1974 Oct;0(10):70-4. Vestn Dermatol Venerol. 1974. PMID: 4432620 Russian. No abstract available.
-
[Methotrexate in the overall therapy of psoriasis].Vestn Dermatol Venerol. 1979 Jun;(6):53-6. Vestn Dermatol Venerol. 1979. PMID: 380215 Clinical Trial. Russian. No abstract available.
-
[Psoriasis and methotrexate. Treatment of 50 cases].Actas Dermosifiliogr. 1974 May-Jun;65(5-6):265-70. Actas Dermosifiliogr. 1974. PMID: 4467699 Spanish. No abstract available.
-
Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.J Eur Acad Dermatol Venereol. 2009 Mar;23(3):277-82. doi: 10.1111/j.1468-3083.2008.03039.x. Epub 2008 Dec 19. J Eur Acad Dermatol Venereol. 2009. PMID: 19207642
-
Toxicity of low dose methotrexate in rheumatoid arthritis.J Rheumatol Suppl. 1985 Dec;12 Suppl 12:35-9. J Rheumatol Suppl. 1985. PMID: 3913775 Review.
Cited by
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2023 Jul 12;7:CD011535. doi: 10.1002/14651858.CD011535.pub6. PMID: 35603936 Free PMC article. Updated.
-
Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes.Hepatology. 2009 Aug;50(2):622-9. doi: 10.1002/hep.23025. Hepatology. 2009. PMID: 19489075 Free PMC article.
-
Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.Drug Saf. 1994 Nov;11(5):318-77. doi: 10.2165/00002018-199411050-00004. Drug Saf. 1994. PMID: 7873092 Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.